Cargando…
Pilot, randomized, placebo-controlled clinical field study to evaluate the effectiveness of bupivacaine liposome injectable suspension for the provision of post-surgical analgesia in dogs undergoing stifle surgery
BACKGROUND: Local anesthetics are an important component of perioperative pain management, but the duration of action of available products is limited. We hypothesized that a single local infiltration of a novel bupivacaine liposome injectable suspension (AT-003) would provide clinically effective a...
Autores principales: | Lascelles, B. Duncan X., Rausch-Derra, Lesley C., Wofford, Jessica A., Huebner, Margie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4988028/ https://www.ncbi.nlm.nih.gov/pubmed/27531019 http://dx.doi.org/10.1186/s12917-016-0798-1 |
Ejemplares similares
-
A Prospective, Randomized, Masked, Placebo‐Controlled Multisite Clinical Study of Grapiprant, an EP4 Prostaglandin Receptor Antagonist (PRA), in Dogs with Osteoarthritis
por: Rausch‐Derra, L., et al.
Publicado: (2016) -
Effect of Bupivacaine Liposome Injectable Suspension on Sensory Blockade and Analgesia for Dupuytren Contracture Release
por: Vandepitte, Catherine F., et al.
Publicado: (2019) -
Liposomal extended-release bupivacaine for postsurgical analgesia
por: Lambrechts, Mark, et al.
Publicado: (2013) -
The Safety of EXPAREL ® (Bupivacaine Liposome Injectable Suspension) Administered by Peripheral Nerve Block in Rabbits and Dogs
por: Richard, Brigitte M., et al.
Publicado: (2012) -
Efficacy profile of liposome bupivacaine, a novel formulation of bupivacaine for postsurgical analgesia
por: Bergese, Sergio D, et al.
Publicado: (2012)